InnoCare Pharma Limited (OTCMKTS:INCPF) Short Interest Down 11.1% in December

InnoCare Pharma Limited (OTCMKTS:INCPF) was the recipient of a significant decrease in short interest during the month of December. As of December 31st, there was short interest totalling 3,295,000 shares, a decrease of 11.1% from the December 15th total of 3,707,000 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is currently ∞ days.

InnoCare Pharma Price Performance

Shares of InnoCare Pharma stock opened at $3.26 on Friday. InnoCare Pharma has a 52 week low of $3.26 and a 52 week high of $3.72. The stock’s fifty day moving average is $3.26 and its two-hundred day moving average is $3.26.

InnoCare Pharma Company Profile

InnoCare Pharma Limited, a biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases. It develops Orelabrutinib, an BTK inhibitor to treat patients with relapsed and/or refractory (r/r) chronic lymphocytic leukemia, r/r mantle cell lymphoma, r/r Waldenstrom's macroglobulinemia, r/r marginal zone lymphoma, r/r diffuse large B-cell lymphoma (DLBCL)- MCD, r/r central nervous system lymphoma, combo w/MIL-62, systemic lupus erythematosus, immune thrombocytopenia purpura, multiple sclerosis, and neuromyelitis optica spectrum disorder.